Sandoz Hits Back At Biosimilar Misinformation
Global Biopharma Head Insists That “Biosimilar Information Battle” Will Be Won
Pierre Bourdage, global head of biopharmaceuticals at Sandoz, has hit back at false statements and misleading claims around biosimilars that persist despite mounting evidence to the contrary.
